Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study

From 1996 to 2000, high-dose chemotherapy with haematopoietic stem-cell support was used as an adjuvant treatment strategy for management of primary high-risk breast cancer patients with more than five positive nodes. This single institution study included 52 women aged &#104 56 years with prima...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta oncologica 2002, Vol.41 (7-8), p.675
Hauptverfasser:	Svane, Inge M, Homburg, Keld M, Kamby, Claus, Nielsen, Dorte L, Roer, Ole, Sliffsgaard, Dorte, Johnsen, Hans E, Hansen, Steen W
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!